TOIIW (The Oncology Institute) Change In Receivables: $-11.73 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TOIIW The Oncology Institute Inc TOIIW
60 GF Score
Price $0.06
! 6 Warning Signs
View Full Analysis

What is The Oncology Institute Change In Receivables?

The Oncology Institute TOIIW 60 Change In Receivables is $-11.73 Mil as of Mar. 2026. GuruFocus rates TOIIW with a GF Score™ of 60/100. The stock has 6 warning signs investors should review.

The Oncology Institute's change in receivables for the quarter that ended in Mar. 2026 was $-0.13 Mil. It means The Oncology Institute's Accounts Receivable increased by $0.13 Mil from Dec. 2025 to Mar. 2026 .

The Oncology Institute's change in receivables for the fiscal year that ended in Dec. 2025 was $-12.58 Mil. It means The Oncology Institute's Accounts Receivable increased by $12.58 Mil from Dec. 2024 to Dec. 2025 .

The Oncology Institute's Accounts Receivable for the quarter that ended in Mar. 2026 was $58.13 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. The Oncology Institute's Days Sales Outstanding for the three months ended in Mar. 2026 was 35.98.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. The Oncology Institute's liquidation value for the three months ended in Mar. 2026 was $-98.49 Mil.

The Oncology Institute  (NAS:TOIIW) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

The Oncology Institute's Days Sales Outstanding for the quarter that ended in Mar. 2026 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=58.134/147.441*91
=35.98

2. In Ben Graham's calculation of liquidation value, The Oncology Institute's accounts receivable are only considered to be worth 75% of book value:

The Oncology Institute's liquidation value for the quarter that ended in Mar. 2026 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=30.28-184.515+0.75 * 58.134+0.5 * 24.29
=-98.49

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Oncology Institute Change In Receivables Related Terms

The Oncology Institute Change In Receivables Historical Data

* Premium members only.

The historical data trend for The Oncology Institute's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Oncology Institute Change In Receivables Chart

The Oncology Institute Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Receivables
Get a 7-Day Free Trial -2.99 -19.67 -4.50 -5.77 -12.58

The Oncology Institute Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.99 -8.21 -4.04 0.66 -0.13
TOIIW
60GF Score
The Oncology Institute Inc TOIIW
Change In Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Oncology Institute Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $-11.73 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $-11.73 Mil mean?
The Oncology Institute (TOIIW) has a Change In Receivables of $-11.73 Mil as of Mar. 2026. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for The Oncology Institute and its competitors.
Is The Oncology Institute's Change In Receivables too high?
The Oncology Institute's current Change In Receivables is $-11.73 Mil. Overall, The Oncology Institute has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does The Oncology Institute's Change In Receivables compare to CYH and SRTA?
The Oncology Institute's Change In Receivables of $-11.73 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Healthcare Providers & Services company?
A good Change In Receivables depends on the Healthcare Providers & Services industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for The Oncology Institute and its competitors. The Oncology Institute's current Change In Receivables is $-11.73 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Oncology Institute stock overvalued right now?
The Oncology Institute (TOIIW) has a current Change In Receivables of $-11.73 Mil. The current Change In Receivables is $-11.73 Mil. The Oncology Institute's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For The Oncology Institute (TOIIW), the current Change In Receivables is $-11.73 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Oncology Institute Business Description

Other Exchanges TOI:USA
Address 18000 Studebaker Road, Suite 800, Cerritos, CA, USA, 90703
The Oncology Institute Inc offers oncology care and treatment services to patients through several clinics located across the United States. It offers services such as infusion chemotherapy, oral drug chemotherapy, hospice and palliative care, autologous stem cell transplants, outpatient blood product transfusions, patient navigator programs, radiation oncology, and others on a fee or value-based model. Additionally, the company enrolls patients in clinical trials, where appropriate. The company has three operating segments: Specialty Pharmacy, Patient Services, and Clinical Trials and Other. Maximum revenue is generated from the Specialty Pharmacy segment, which operates specialty and retail pharmacies providing IV-infused, oral, injectable, and other medications for oncology treatment.
60GF Score

Get the complete analysis for TOIIW

Change In Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.06
Price